Emergency: 9010550550
24/7 Service

Strengthen Bones in Kidney Failure

CKD-MBD experts balancing calcium, phosphorus, and PTH with precision therapy

Book CKD-MBD Clinic
88%
PTH Stabilisation
Patients achieve KDIGO target range in 6 months
70%
Fracture Risk Reduction
Measured via FRAX and bone density follow-up
96%
Adherence
Maintained with digital reminders and diet coaching

When to Consult

  • Bone pain, joint stiffness, or muscle cramps
  • Frequent fractures or reduced height
  • High PTH, calcium, or phosphorus on lab reports
  • Dialysis patients with itching or vascular calcification
  • Pre-transplant patients needing bone health optimisation
  • Children with CKD showing growth delays

Understanding Bone Disease in Kidney Failure

Chronic kidney disease disrupts mineral metabolism, leading to fragile bones, joint pain, and vascular calcification. Ajuda Hospitals' CKD-MBD clinic combines nephrology, endocrinology, and physiotherapy expertise to restore balance and prevent fractures.

Patients from Hyderabad's IT corridors and nearby districts benefit from bilingual counselling, diet plans, and tele follow-up. Early intervention means better mobility, fewer fractures, and readiness for transplant evaluation.

When to Consult Our CKD-MBD Specialists

⚠️ Seek Immediate Care If You Experience:

  • ✓ Sudden bone pain or suspected fracture
  • ✓ Persistent itching with high phosphorus levels
  • ✓ Severe muscle cramps or spasms
  • ✓ Vascular calcification noted on imaging

Arrange a review if your labs show elevated PTH, calcium, or phosphorus, or if you experience restless legs and muscle weakness. Children with CKD need early evaluation to protect growth.

Our Diagnostic Approach

Mineral & Hormone Profiling

Regular monitoring of calcium, phosphorus, PTH, vitamin D, and alkaline phosphatase directs therapy. Acid-base status is reviewed to prevent metabolic bone disease.

Imaging & DEXA

Bone density scans, spine X-rays, and vascular calcification assessments identify fracture risk and soft tissue calcifications.

Dialysis & Medication Audit

Dialysis adequacy, dialysate calcium concentration, and adherence to phosphate binders are reviewed. Medications causing bone loss are adjusted.

Nutrition & Lifestyle Review

Dietitians map phosphate intake from staples like idli, dosa, and processed foods, recommending low-phosphate alternatives and cooking techniques.

Treatment Pathways

Ajuda adheres to KDIGO CKD-MBD guidelines:

  • Vitamin D Therapy: Active analogues and supplementation correct deficiencies.
  • Calcimimetics: Cinacalcet or etelcalcetide balance PTH in dialysis patients.
  • Phosphate Control: Binders plus tailored diets reduce phosphorus load.
  • Dialysis Optimisation: Adjust sessions and dialysate composition.
  • Fracture Prevention: Physiotherapy, fall risk assessment, and targeted pharmacotherapy.
  • Paediatric Programs: Growth hormone assessment, orthopaedic support, and counselling for children.

What to Expect: Your Care Journey

  1. Baseline Evaluation: Labs, DEXA, and dialysis review with nephrologist and dietitian.
  2. Therapy Initiation (Weeks 1-4): Vitamin D or calcimimetics started; binder plans refreshed; physiotherapy introduced.
  3. Monitoring Phase (Months 2-3): Monthly labs ensure PTH and phosphate trends improve; dietary adherence reinforced.
  4. Long-term Maintenance (6 Months onwards): Quarterly reviews, annual DEXA, and tele consults support sustained bone health.

Technology & Innovation

The CKD-MBD Monitoring Platform links lab results, medication schedules, and physiotherapy notes. Alerts prompt binder refills and schedule DEXA scans. Patients receive WhatsApp tips on low-phosphate recipes and exercise routines.

Preventing Complications

By balancing minerals, we reduce fracture risk, heart valve calcification, and vascular stiffness. Early detection prevents disabling bone pain and supports transplant readiness. Physiotherapy improves balance and mobility.

Why Ajuda for CKD Bone Care?

🩺 Multispecialty Clinic

Nephrologists, endocrinologists, and physiotherapists collaborate on every case.

🥛 Dietitian Support

Meal plans cover low-phosphate versions of Telugu favourites like pesarattu and ragi malt.

📈 Continuous Monitoring

Digital dashboards and WhatsApp updates keep labs on track without frequent hospital visits.

Take the First Step

Protect your bones while managing kidney disease. Call 9010550550 or message Ajuda Hospitals on WhatsApp to schedule your CKD-MBD assessment and personalised therapy plan.

Diagnosis Approach

1

Mineral Profile

Serum calcium, phosphorus, alkaline phosphatase, PTH, vitamin D levels, and bicarbonate.

2

Bone Density & Imaging

DEXA scans, X-rays, and vascular calcification assessments.

3

Dialysis Adequacy Review

Kt/V, dialysate calcium, and phosphate binder compliance.

4

Endocrine & Nutrition Assessment

Dietary phosphate intake, hormonal evaluation, and medication review.

Treatment Options

Vitamin D & Calcium Correction

Active vitamin D analogues (calcitriol, alfacalcidol) and controlled calcium supplements.

Improves bone pain in 75% of patients.
8-12 weeks with maintenance

Calcimimetic Therapy

Cinacalcet or etelcalcetide titrated based on PTH levels for secondary hyperparathyroidism.

Reduces PTH by 40-60%.
Long-term with monthly monitoring

Phosphate Binder Optimisation

Sevelamer, lanthanum, or sucroferric oxyhydroxide with meal planning to reduce phosphate load.

Keeps serum phosphorus within 3.5-5.5 mg/dL.
Ongoing

Dialysis Prescription Adjustments

Alter dialysate calcium, extend sessions, and add nocturnal dialysis when needed.

Improves mineral balance in resistant cases.
As prescribed

Fracture Prevention & Rehab

Physiotherapy, fall risk assessment, and bisphosphonate/denosumab therapy where appropriate.

Cuts fracture incidence by 50%.
12-week rehab with annual review

Paediatric CKD-MBD Program

Growth hormone evaluation, nutritional support, and skeletal monitoring for children.

Supports linear growth and reduces deformities.
Individualised

Expected Outcomes

Treatment Timeline

6 Weeks

Symptom relief with vitamin D and binder adjustments

3 Months

PTH trending into target range

6-9 Months

Improved bone density and reduced fracture risk

1 Year+

Stable mineral balance with enhanced mobility

Success Metrics

  • PTH within KDIGO recommended range
  • Phosphorus controlled at 3.5-5.5 mg/dL
  • No new fragility fractures